Operating margin · Fiscal year 2025
| 1 | Royalty PharmaRPRX | 65.6% |
|---|---|---|
| 2 | PTC TherapeuticsPTCT | 50.1% |
| 3 | United TherapeuticsUTHR | 46.9% |
| 4 | Novo Nordisk A SNVO | 41.3% |
| 5 | NovavaxNVAX | 40.3% |
| 6 | Eli LillyLLY | 39.5% |
| 7 | ExelixisEXEL | 37.6% |
| 8 | ZoetisZTS | 35.5% |
| 9 | Vertex PharmaceuticalsVRTX | 34.8% |
| 10 | Johnson & JohnsonJNJ | 34.6% |